Inhibition of left ventricular fibrosis by tranilast in rats with renovascular hypertension

Journal of Hypertension

Volumn 20, Issue 4, 2002, Pages 745-751

  Hocher, Berthold ^a   Godes, Michael ^a   Olivier, Jan ^a   Weil, Joachim ^a   Eschenhagen, Thomas ^a   Slowinski, Torsten ^a   Neumayer, Hans H ^a   Bauer, Christian ^a   Paul, Martin ^a   Pinto, Yigal M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cardiac fibrosis; Renovascular hypertension; Tranilast

Indexed keywords

QUINAPRIL; TRANILAST;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART WEIGHT; IMAGE ANALYSIS; IN VITRO STUDY; LONG TERM CARE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; RENOVASCULAR HYPERTENSION;

EID: 0036528804     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200204000-00034     Document Type: Article

References (33)

1. The collagen network of the heart
2. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system
3. Renin-angiotensin system and myocardial collagen matrix remodeling in hypertensive heart disease: In vivo and in vitro studies on collagen matrix regulation
4. Fibrosis-induced reduction of endemyocardium in the rat after isoproterenol treatment
5. Arrhythmia susceptibility and myocardial composition in diabetes. Influence of physical conditioning
6. The role of local disparity in conduction and recovery time on ventricular vulnerability to fibrillation
7. Proinflammatory consequences of transgenic fas ligand expression in the heart
8. Cardiac remodeling by fibrous tissue after infarction in rats
9. Hypertension-induced end-organ damage: A new transgenic approach to an old problem
10. Differential protein expression and subcellular distribution of TGFbeta1, beta2 and beta3 in cardiomyocytes during pressure overload-induced hypertrophy
11. Myocardial remodeling in hypertensive Ren-2 transgenic rats
12. Contribution of local renin-angiotensin system to cardiac hypertrophy, phenotypic modulation, and remodeling in TGR (mRen2)27 transgenic rats
13. Reduction in left ventricular messenger RNA for transforming growth factor b1 attenuates left ventricular fibrosis and improves survival without lowering blood pressure in the hypertensive TGR(mRen2)27 rat
14. The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts
15. Inhibitory effect of tranilast on activation and transforming growth factor beta 1 expression in cultured rat stellate cells
16. Effectiveness of tranilast on restenosis after directional coronary atherectomy
17. Endothelin system dependent cardiac remodeling in renovascular hypertension
18. Inhibition by tranilast of collagen accumulation in hypersensitive granulomatous inflammation in vivo and of morphological changes and functions of fibroblasts in vitro
19. Tranilast suppresses intimal hyperplasia in the balloon injury model and cuff treatment model in rabbits
20. Paracrine renal endothelin system in rats with liver cirrhosis
21. Pulmonary fibrosis and chronic lung inflammation in ET-1 transgenic mice
22. Induction and nuclear accumulation of Fos and Jun proto-oncogenes in hypoxic cardiac myocytes
23. Inhibitory effects of tranilast on expression of transforming growth factor-beta isoforms and receptors in injured arteries
24. Identification of tranilast-binding protein as 36-kDa microfibril-associated glycoprotein by drug affinity chromatography, and its localization in human skin
25. Inhibition by tranilast of collagen accumulation in hypersensitive granulomatous inflammation in vivo and of morphological changes and functions of fibroblasts in vitro
26. Antiproliferative and c-myc mRNA suppressive effect of tranilast on newborn human vascular smooth muscle cells in culture
27. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases
28. Aldosterone antagonists in hypertension and heart failure
29. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators
30. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Marked upregulation of genes encoding extracellular matrix components
31. Extracellular matrix remodeling in heart failure: A role for de novo angiotensin II generation
32. Inhibition of neointima formation by tranilast in pig coronary arteries after balloon angioplasty and stent implantation
33. Tranilast suppresses vascular chymase expression and neointima formation in balloon-injured dog carotid artery